Elevance Health has sued the U.S. government, alleging that federal efforts to recalculate its Medicare Advantage quality ...

We’ve reached the midpoint of the year and, wow, biotech has gone nuts. The sector’s performance in June was especially ...

Biotech's bull market, Vertex's gene therapy expansion, and more news from The Readout ...

The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund breakthroughs in the understanding and treatment of bipolar disorder and schizophrenia research. The ...

Sources confirm to STAT that Marburg cases have been detected in western Uganda, adding another viral hemorrhagic fever ...

The newly cleared device is based around an app that helps a patient manage their diabetes using a treatment plan defined by ...

CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.

Companies are being too conservative in how they interpret FDA's AI guidance, but the agency can do more to help, too, Tala ...

What is urgently needed is a shift from pathogen-specific diagnostics toward pathogen-agnostic diagnostic systems,” write ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Amylyx ...

Demand for alcohol is declining. The industry is fighting harder and more creatively than ever against limits — and winning.

Today's health tech news includes virtual PT for a whole country, what the FDA is considering on AI policy, and more ...